& Mahy, N
Neelakantan and colleagues (Biochem Pharmacol, 2018) reported that 1-methylquinolinium and 1-methylnicotinamide showed no measurable passive diffusion in their assays, whereas 5-amino-1MQ crossed by both passive and active routes with no detectable efflux in Caco-2 cells, and lowered intracellular 1-methylnicotinamide in differentiated 3T3-L1 adipocytes with an EC near 2.3 M
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Pejic S., Todorovic A., Stojiljkovic V., Cvetkovic D., Lucic N., Radojicic R.M., Saicic Z.S., Pajovic S.B
With continued acid exposure there is injury to the distal oesophageal mucosa and dilated intracellular spaces are seen histologically
This study continued that pattern: No serious adverse events were reported in any patient Minor injection site reactions (mild redness or swelling) were reported in 15% of patients and resolved without intervention No systemic effects, no changes in standard bloodwork panels No interactions with concurrent medications were observed This safety record across both animal and now human data is part of what makes BPC-157 a credible candidate for broader clinical adoption